In focus · trending topic

Caelum Biosciences

1 stories · following the connections

Caelum Biosciences Announces Data on CAEL-101 in AL Amyloidosis Selected for Oral Presentation at 59th American Society of Hematology Annual Meeting

By Nasdaq OMXNov 1, 2017, 1:05 PM UTC